Revitope Inc, 700 Main St, Cambridge, MA 02139, US

Nanobiotix Corp is a biotechnology company based in Cambridge, MA that specializes in the development of innovative cancer therapies. They have recently achieved a significant $20 million development milestone payment for their ongoing global Phase 3 Head and Neck Cancer Study, and have also raised $55 million through a capital increase. With a strong focus on research and development, Nanobiotix is dedicated to advancing their science pipeline and collaborating with partners to bring effective treatments to patients. Through their cutting-edge technology, Nanobiotix aims to revolutionize cancer treatment by leveraging nanomedicine to enhance the efficacy of radiation therapy. Their preliminary results from Phase 1 trials in pancreatic cancer and head and neck cancer have shown promising outcomes, further highlighting their commitment to improving patient outcomes. With a dedicated team of leaders, a scientific advisory board, and a strong presence in the media and investor community, Nanobiotix is poised to make a significant impact in the field of oncology.Generated from the website

Capgemini

1910 Genetics

Diversified Project Management Inc

Colliers International